@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix this: <http://purl.org/np/RAT63vyXgtJrPWavpB5UiJvFoODu3Y-PSF26iQyDWVn5w> .
@prefix sub: <http://purl.org/np/RAT63vyXgtJrPWavpB5UiJvFoODu3Y-PSF26iQyDWVn5w#> .
@prefix drugbank: <http://identifiers.org/drugbank/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix mondo: <http://purl.obolibrary.org/obo/MONDO_> .
@prefix pav: <http://purl.org/pav/> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix pmid: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix efo: <http://www.ebi.ac.uk/efo/EFO_> .
@prefix ncit: <http://purl.obolibrary.org/obo/NCIT_> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

<http://purl.org/np/RAT63vyXgtJrPWavpB5UiJvFoODu3Y-PSF26iQyDWVn5w> a np:Nanopublication;
  np:hasAssertion sub:assertion;
  np:hasProvenance sub:provenance;
  np:hasPublicationInfo sub:pubInfo;
  prov:generatedAtTime "2022-09-16T11:47:56.810730"^^xsd:dateTime;
  prov:wasAttributedTo orcid:0000-0002-1501-1082;
  nt:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .

drugbank:DB00996 a biolink:Drug;
  rdfs:label "Gabapentin";
  biolink:category biolink:Drug .

<http://purl.obolibrary.org/obo/MONDO_0100081> a biolink:Disease;
  rdfs:label "sleep disorder";
  biolink:category biolink:Disease .

sub:association a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
  rdf:object <http://purl.obolibrary.org/obo/MONDO_0100081>;
  rdf:predicate biolink:treats;
  rdf:subject drugbank:DB00996;
  rdfs:label "However, there are no sleep medications approved by the United States Food and Drug Administration and only one has been approved by the European Medicines Agency for pediatric insomnia; thus, most medications are prescribed off-label. Melatonin is widely used and safe in children with neurodevelopmental conditions. Gabapentin, clonidine, trazodone, and mirtazapine hold promise but require further study.";
  biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
  biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
  biolink:has_population_context sub:context;
  biolink:publications pmid:31638842;
  biolink:relation <http://purl.obolibrary.org/obo/NCIT_C94303> .

sub:context a biolink:Cohort;
  rdfs:label "Children";
  biolink:category biolink:Cohort;
  biolink:has_phenotype <http://www.ebi.ac.uk/efo/EFO_0010642> .

sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .

sub:sig npx:hasAlgorithm "RSA";
  npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
  npx:hasSignature "dovhlNU7QeFtFWGhwdl6hmGXl4aBAYjRPgfSuEAEhRhwXG2zAHXUue9w72ZM3c+kTWWe33cTe4nYjymU/OYa8nuTRBSMsJJ7fTW+IbxU4i4pUQYA/7wmM0OoB4PoZpbmJe/IogwPCRJsY5cvIQZLqUkiYBiDLWoCnowEKYeVAcU=";
  npx:hasSignatureTarget <http://purl.org/np/RAT63vyXgtJrPWavpB5UiJvFoODu3Y-PSF26iQyDWVn5w> .

<https://w3id.org/biolink/vocab/> pav:version "2.3.0" .